EY US unveils Jeff Elton of ConcertAI as an Entrepreneur Of The Year
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Ernst & Young LLP (EY US) has announced the finalists for the prestigious Entrepreneur Of The Year 2025 New England Award. Now in its 40th year, the Entrepreneur Of The Year program celebrates the bold leaders who disrupt markets through the world's most ground-breaking companies, revolutionizing industries and making a profound impact on communities. The program honors bold entrepreneurs whose innovations shape the future and pave the way for a thriving economy and a hopeful tomorrow.
An independent panel of judges selected Jeff Elton, among 31 finalists for their entrepreneurial spirit, purpose, growth and lasting impact in building long-term value.
ConcertAI is the leader in oncology generative and agentic AI SaaS and multi-modal data (MMD) solutions for healthcare and life sciences. Its AI-powered solutions augment clinical decision-making, accelerate critical research, and generate the evidence to improve cancer patient outcomes worldwide. Under Jeff Elton's leadership, ConcertAI has set the standard for data-driven, AI-powered oncology care, research, and technology-enabled solutions supporting the overall patient journey.
"This finalist recognition from the Entrepreneur Of The Year New England award program is an incredible honor—not just for me, but for the entire ConcertAI team and our partners,' said Jeff Elton, PhD, CEO at ConcertAI. 'It validates and reflects our mission of transforming and improving cancer research and care, where AI and data at population scale can provide clinicians and biopharma innovators the most advanced solutions for patients with the highest unmet medical needs and most complex care."
Entrepreneur Of The Year honors business leaders for their ingenuity, courage and entrepreneurial spirit. The program celebrates original founders who bootstrapped their business from inception or who raised outside capital to grow their company; transformational CEOs who infused innovation into an existing organization to catapult its trajectory; and multigenerational family business leaders who reimagined a legacy business model to strengthen it for the future.
Regional award winners will be announced on Wednesday, June 11 th during a special celebration in Boston, MA and will become lifetime members of an esteemed community of Entrepreneur Of The Year alumni from around the world. The winners will then be considered by the National judges for the Entrepreneur Of The Year National Awards, which will be presented in November at the annual Strategic Growth Forum ®, one of the nation's most prestigious gatherings of high-growth, market-leading companies.
About ConcertAI
ConcertAI is the leader in predictive and generative AI SaaS and real-world data research solutions for healthcare and life sciences. Our mission is to accelerate insights and outcomes for patients through research-ready data, CARAai™ technologies, and scientific expertise in partnership with over 46 leading biomedical innovators, 2,000 healthcare providers, and medical societies. TeraRecon provides advanced radiological image visualizations and clinical AI decision augmentation solutions for MRI and CT. CancerLinQ® is an initiative of ConcertAI, providing oncology providers with ASCO-aligned automated QOPI and ASCO Certified® quality solutions and SmartLinQ™ analytic services. Headquartered in Cambridge, MA, ConcertAI has offices in Bangalore, Frankfurt, Philadelphia, Raleigh-Durham, and Tokyo. For more information, visit us at concertai.com.
Sponsors
Founded and produced by Ernst & Young LLP, the Entrepreneur Of The Year Awards include presenting sponsors PNC Bank, Cresa, LLC, Marsh USA, and SAP. In New England, sponsors also include regional Platinum sponsor, DLA Piper, regional Gold sponsor, Selective Insight, and regional Silver sponsor, ADP.
About Entrepreneur Of The Year
Founded in 1986, Entrepreneur Of The Year has celebrated more than 11,000 ambitious visionaries who are leading successful, dynamic businesses in the US, and it has since expanded to nearly 60 countries globally.
The US program consists of 17 regional programs whose panels of independent judges select the regional award winners every June. Those winners compete for national recognition at the Strategic Growth Forum ® in November where National finalists and award winners are announced. The overall National winner represents the US at the EY World Entrepreneur Of The Year™ competition. Visit ey.com/us/eoy.
About EY
EY is building a better working world by creating new value for clients, people, society and the planet, while building trust in capital markets.
Enabled by data, AI and advanced technology, EY teams help clients shape the future with confidence and develop answers for the most pressing issues of today and tomorrow.
EY teams work across a full spectrum of services in assurance, consulting, tax, strategy and transactions. Fueled by sector insights, a globally connected, multi-disciplinary network and diverse ecosystem partners, EY teams can provide services in more than 150 countries and territories.
All in to shape the future with confidence.
EY refers to the global organization, and may refer to one or more, of the member firms of Ernst & Young Global Limited, each of which is a separate legal entity. Ernst & Young Global Limited, a UK company limited by guarantee, does not provide services to clients. Information about how EY collects and uses personal data and a description of the rights individuals have under data protection legislation are available via ey.com/privacy. EY member firms do not practice law where prohibited by local laws. For more information about our organization, please visit ey.com.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
7 minutes ago
- Yahoo
Cloud Range to Showcase Cutting-Edge Cybersecurity Simulations at 2025 Gartner Security & Risk Management Summit
Industry Leader Highlights Innovations in Cyber Preparedness Training NASHVILLE, Tenn., June 09, 2025--(BUSINESS WIRE)--Cloud Range, the leading enterprise cyber range platform for reducing detection and response times thereby reducing cyber risk, today announced it will showcase its latest innovations in cyber readiness and pre-emptive preparedness at the 2025 Gartner Security & Risk Management Summit, June 9–11 in National Harbor, MD. At the summit, Cloud Range will demonstrate its latest advancements, including the award-winning Range365™ platform—a fully managed, cloud-based cyber range with customizable IT and OT/ICS environments. Range365 strengthens security teams to engage in realistic attack scenarios, directly reducing cyber risk. Additionally, Cloud Range will showcase its Performance Portal, a comprehensive learning management system (LMS) providing detailed analytics on individual and team performance, enabling targeted, continuous skill development aligned to organizational needs. "The Gartner Summit is a pivotal event that brings together the brightest minds in cybersecurity," said Debbie Gordon, CEO and Founder of Cloud Range. "As cyber threats become increasingly sophisticated, it's clear that tools and tech stacks alone are not enough. From global enterprises to top universities, organizations must recognize that people—not just technology—are at the core of cyber defense. Our mission is to ensure SOC and incident response teams are always ready through immersive, real-world training programs that provide hands-on experience, build confidence, and help ensure resilience. Our presence at the summit underscores our commitment to advancing cyber defense capabilities across industries." Cloud Range's innovative approach has garnered significant recognition, including the 2025 SC Award for Best IT Security-Related Training Program and the 2025 Global InfoSec Award for Visionary Cybersecurity Training. These accolades and others reflect the company's dedication to providing cutting-edge solutions that address the evolving needs of cybersecurity professionals. Beyond enterprise solutions, Cloud Range is actively involved in shaping the future of cybersecurity education. Through collaborations with initiatives like IBM's Cyber Campus and partnerships with organizations such as Cyviz, Cloud Range is integrating its simulation technology into academic curricula, providing students with practical, real-world skills and experience to bridge the gap between theoretical knowledge and real-world application. It's a true redefinition of the student journey. For more information about Cloud Range's offerings or to schedule a demonstration at the Gartner Security & Risk Management Summit, visit: About Cloud Range Cloud Range is the first cyber Range-as-a-Service, delivering fully customizable cyberattack simulation training to prepare security teams for real-world threats. Trusted by enterprise SOCs, MSSPs, government agencies, higher education institutions, utilities, and critical infrastructure, Cloud Range helps organizations accelerate cyber defense skills and reduce risk. With Cloud Range's immersive, on-demand platform, customers can train teams, assess talent, onboard new hires, and upskill cybersecurity professionals—without needing costly physical labs or red teams. Recent recognition includes the 2025 SC Award for Best IT Security Training Program, the 2025 Global InfoSec Award for Visionary in Cybersecurity Training, the CISO Choice Award, and more. Stay ahead of threats with hands-on cyber readiness. Explore Cloud Range at View source version on Contacts Media Contact Leslie KesselringKesselring Communications for Cloud Rangeleslie@ 503-358-1012 Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
10 minutes ago
- Yahoo
GoodRx Launches Community Link to Offer Independent Pharmacies Cost-Plus Pricing
Community Link allows independent pharmacies to direct contract with GoodRx, manage participation in the company's Integrated Savings Program, and access over 90 brand medication partnership offerings Cost-plus pricing is anchored on NADAC Starting July 1, all independent pharmacies will be opted out of GoodRx's Integrated Savings Program by default SANTA MONICA, Calif., June 09, 2025--(BUSINESS WIRE)--GoodRx (Nasdaq: GDRX), the leading platform for medication savings in the U.S., today announced the launch of GoodRx Community Link. Designed to address the industry challenges that independent community pharmacies face around complex reimbursement models and competitive pressures, Community Link leverages a cost-plus pricing model based on NADAC to provide predictable pricing and favorable economics. This announcement showcases GoodRx's commitment to helping independent pharmacies better manage pricing while continuing to provide consumers with affordable prices on their medications. "We know independent pharmacies are critical pillars in our communities that help millions of Americans access their medications and they need bespoke solutions to help address the industry problems they face," said Aaron Crittenden, President of Rx Marketplace at GoodRx. "GoodRx Community Link is the result of a multi-year journey to evolve the GoodRx business model and deliver solutions tailored to the specific needs of independent pharmacies. Ultimately, our goal with Community Link is to help improve the retail pharmacy business model and support a bright future for the sector." Community Link enables independent pharmacies to: Direct Contract with GoodRx: Leverages cost-plus pricing anchored on NADAC to provide independent pharmacies with direct control over pricing and favorable margins. A direct contract means the pricing relationship is entirely between GoodRx and the pharmacy, with no PBM involvement. Entering into a direct agreement with GoodRx does not waive a pharmacy's right to participate in ongoing litigation against GoodRx. Manage Participation in GoodRx's Integrated Savings Program (ISP): When a direct contract is signed, independent pharmacies will have the ability to opt-in to ISP as an additional benefit of working with GoodRx. Starting July 1, all independent pharmacies will be opted out of ISP by default. ISP participation may offer more favorable rates than traditional commercial insurance reimbursement. Access Over 90 Brand Medication Deals: A unique offering where the manufacturer buys down the price of a brand medication via GoodRx, making it more affordable for the consumer and economically beneficial for the pharmacy. Examples include Lantus, a Humira® biosimilar, and medical devices such as Dexcom. Starting today, independent pharmacies can use their NCPDP number to login to GoodRx Community Link and manage their relationship with GoodRx: To view a recording of the GoodRx Community Link webinar that was hosted last week, visit: For any questions, please reach out to: communitylink@ About GoodRx GoodRx is the leading platform for medication savings in the U.S., used by nearly 30 million consumers and over one million healthcare professionals annually. Uniquely situated at the center of the healthcare ecosystem, GoodRx connects consumers, healthcare professionals, payers, PBMs, pharma manufacturers, and retail pharmacies to make saving on medications easier. By reducing friction and inefficiencies, GoodRx helps consumers save time and money when filling prescriptions so they can get the care they deserve. Since 2011, GoodRx has helped Americans save over $85 billion on the cost of their medications. GoodRx periodically posts information that may be important to investors on its investor relations website at We intend to use our website as a means of disclosing material nonpublic information and for complying with our disclosure obligations under Regulation FD. Accordingly, investors and potential investors are encouraged to consult GoodRx's website regularly for important information, in addition to following GoodRx's press releases, filings with the Securities and Exchange Commission (the "SEC") and public conference calls and webcasts. The information contained on, or that may be accessed through, GoodRx's website is not incorporated by reference into, and is not a part of, this press release. GoodRx Forward-Looking Statements This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. All statements contained in this press release that do not relate to matters of historical fact should be considered forward-looking statements, including, without limitation, statements regarding anticipated savings, convenience and accessibility; the expected benefits and value of GoodRx Community Link and our Integrated Savings Programs; and our plans, expectations and objectives. These statements are neither promises nor guarantees, but involve known and unknown risks, uncertainties and other important factors that may cause our actual results, performance or achievements to be materially different from any future results, performance or achievements expressed or implied by the forward-looking statements, including, but not limited to, risks relating to our ability to achieve broad market education and change consumer purchasing habits; changes in medication pricing and pricing structures; our reliance on a limited number of industry participants; and the important factors discussed under the caption "Risk Factors" in our Annual Report on Form 10-K for the year ended December 31, 2024, and our other filings with the SEC. Any such forward-looking statements are based on current expectations, projections and estimates as of the date of this press release. While we may elect to update such forward-looking statements at some point in the future, we disclaim any obligation to do so, even if subsequent events cause our views to change. View source version on Contacts Media Contact press@ Sign in to access your portfolio
Business Wire
11 minutes ago
- Business Wire
PHINIA Makes Paris Air Show Debut, Signaling Strategic Entry into Aerospace Market
PARIS--(BUSINESS WIRE)-- PHINIA Inc. (NYSE:PHIN), a leader in premium fuel systems, electrical systems, and aftermarket solutions, has announced its inaugural presence at the world's most prestigious aerospace industry trade show, the Paris Air Show 2025. Taking place between 16-22 June at Le Bourget Exhibition Center in Paris, PHINIA's debut at the event marks a significant step in the company's expansion into the aerospace industry. PHINIA will be exhibiting in Hall 4, Stand E97, where it will showcase its advanced capabilities in complex component manufacturing well suited for advanced aerospace propulsion systems. Known for its deep heritage in fuel systems and combustion technologies for automotive and high-performance applications, PHINIA is bringing its expertise to meet the complex, fast-evolving needs of the aerospace industry. The company's attendance at the world's largest air and space exhibition underscores its commitment to becoming a long-term, high-value partner in the global aerospace supply chain. 'With a strong foundation in sub-micron manufacturing, precision fluid management, system integration, and alternative fuel combustion, we are well positioned to support both current and next-generation aerospace propulsion systems,' said Brady Ericson, President and Chief Executive Officer, PHINIA. 'Our debut at the Paris Air Show is a natural evolution of our capabilities and a clear signal that PHINIA is ready to contribute meaningfully to the future of flight.' Already trusted by leading aerospace manufacturers, PHINIA is currently delivering two production programs launching in 2025 and 2026, as well as an advanced development project for future aerospace applications. These aerospace programs are well aligned with PHINIA's current expertise. PHINIA has a global footprint and proven agility in fast-track development, as well as a dedicated aerospace product line team and production line. The company is actively pursuing additional opportunities across both military and civil aviation. Visit PHINIA at Paris Air Show – Hall 4, Stand E97 – to learn how we're powering a cleaner tomorrow for the aerospace industry. Visit for more information. About PHINIA PHINIA is an independent, market-leading, premium solutions and components provider, with over 100 years of manufacturing expertise and industry relationships and a strong brand portfolio that includes DELPHI ®, DELCO REMY ® and HARTRIDGE™. With over 12,500 employees across 43 locations in 20 countries, PHINIA is headquartered in Auburn Hills, Michigan, USA. Across commercial vehicles and industrial applications (medium-duty and heavy-duty trucks, buses and other off-highway construction, marine, agricultural and aerospace and defense), light commercial vehicles (vans and trucks) and light passenger vehicles (passenger cars, mini-vans, cross-overs and sport-utility vehicles), we develop fuel systems, electrical systems, and aftermarket solutions designed to keep combustion engines operating at peak performance, while at the same time investing in advanced technologies to unlock the potential of alternative fuels. By providing what the market needs today to become more efficient and sustainable, while also developing innovative products and solutions to contribute to lower carbon mobility, we are the partner of choice for a diverse array of customers – powering our shared journey toward a cleaner tomorrow. © 2025 PHINIA Inc. All Rights Reserved.
